Allarity Therapeutics's total assets for Q2 2025 were $21.20M, a decrease of -28.67% from the previous quarter. ALLR total liabilities were $9.04M for the fiscal quarter, a -18.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.